MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jhbp.70180

Медицинская библиотека · Journal of hepato-biliary-pancreatic sciences · 2026

Pretreatment Contrast-Enhanced Harmonic EUS Predicts Pathological Response and Recurrence-Free Survival After Multimodal Treatment in Resectable Pancreatic Cancer.

Kano Yuichi, Ishikawa Takuya, Yamao Kentaro, Mizutani Yasuyuki, Iida Tadashi, Takada Yoshihisa, Kumano Ryohei, Yamamura Takeshi, Furukawa Kazuhiro, Kawashima Hiroki

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

Recurrence remains common in resectable pancreatic cancer (PC) despite multimodal treatment. We evaluated whether pretreatment contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) predicts pathological response and recurrence-free survival (RFS).

METHODS

We retrospectively analyzed 52 patients with resectable PC who underwent CH-EUS before standardized multimodal treatment (neoadjuvant chemotherapy, surgery, and adjuvant chemotherapy). Associations between CH-EUS enhancement patterns (iso- or hypoenhancement) at 20, 40, and 60 s and pathological response were assessed. Associations with RFS were analyzed using Kaplan-Meier and Cox regression analyses.

RESULTS

Hypoenhancement was associated with significantly lower pathological response rates at all phases. Median RFS was significantly shorter in the hypoenhancement group at 20 s (560 vs. 1296 days; p = 0.018), 40 s (683 days vs. not reached; p = 0.013), and 60 s (779 days vs. not reached; p = 0.034). In multivariate analysis, hypoenhancement at 20 s independently predicted shorter RFS (HR 2.49, 95% CI 1.01-6.09; p = 0.047).

CONCLUSIONS

Pretreatment CH-EUS predicts pathological response and recurrence risk in resectable PC. In particular, 20-s enhancement provides a simple, reproducible imaging biomarker that may support pre-treatment risk stratification and potentially guide individualized management strategies.

Для цитирования: Kano Yuichi, Ishikawa Takuya, Yamao Kentaro, Mizutani Yasuyuki, Iida Tadashi, Takada Yoshihisa, Kumano Ryohei, Yamamura Takeshi, Furukawa Kazuhiro, Kawashima Hiroki. Pretreatment Contrast-Enhanced Harmonic EUS Predicts Pathological Response and Recurrence-Free Survival After Multimodal Treatment in Resectable Pancreatic Cancer.. Journal of hepato-biliary-pancreatic sciences. 2026. DOI: 10.1002/jhbp.70180.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.